Study to Evaluate D2 Receptor Occupancy Following Single Intravenous Administration of ATI-9242

计划入组 7 人 · 首次发布于 2016 年 7 月 7 日

Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649)

计划入组 26 人 · 首次发布于 2011 年 10 月 13 日

Study of Safety and Pharmacokinetics of MK-8242 in Participants With Advanced Solid Tumors (P07650)

计划入组 48 人 · 首次发布于 2011 年 11 月 2 日

L24

EP-1242

ATI-9242

Spleen-Targeted mRNA Vaccine Shows Promise Against Hepatocellular Carcinoma in Preclinical Studies

Frontier Medicines Unveils FMC-242, Novel PI3Kα/RAS Inhibitor Targeting Cancer's Most Common Genetic Drivers